| 000 | 01691 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516124340.0 | ||
| 264 | 0 | _c20130619 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1952-4013 | ||
| 024 | 7 |
_a10.1684/ejd.2012.1862 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatsatsi, Aikaterini | |
| 245 | 0 | 0 |
_aPyoderma gangrenosum in a patient with primary cutaneous peripheral T-cell lymphoma, not otherwise specified. _h[electronic resource] |
| 260 |
_bEuropean journal of dermatology : EJD _c |
||
| 300 |
_a792-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
| 650 | 0 | 4 |
_aDermatologic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, T-Cell, Cutaneous _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPrednisolone _xadministration & dosage |
| 650 | 0 | 4 |
_aPyoderma Gangrenosum _xcomplications |
| 650 | 0 | 4 |
_aSkin Neoplasms _xcomplications |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aKoletsa, Triantafyllia | |
| 700 | 1 | _aSotiriadis, Dimitrios | |
| 700 | 1 | _aKartsios, Charalambos | |
| 700 | 1 | _aPapaconstantinou, Antonios | |
| 700 | 1 | _aKostopoulos, Ioannis | |
| 773 | 0 |
_tEuropean journal of dermatology : EJD _gvol. 22 _gno. 6 _gp. 792-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1684/ejd.2012.1862 _zAvailable from publisher's website |
| 999 |
_c22335984 _d22335984 |
||